BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 8440413)

  • 1. A 1-hour pulse with IL-1 beta induces formation of nitric oxide and inhibits insulin secretion by rat islets of Langerhans: evidence for a tyrosine kinase signaling mechanism.
    Corbett JA; Sweetland MA; Lancaster JR; McDaniel ML
    FASEB J; 1993 Feb; 7(2):369-74. PubMed ID: 8440413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide and cyclic GMP formation induced by interleukin 1 beta in islets of Langerhans. Evidence for an effector role of nitric oxide in islet dysfunction.
    Corbett JA; Wang JL; Hughes JH; Wolf BA; Sweetland MA; Lancaster JR; McDaniel ML
    Biochem J; 1992 Oct; 287 ( Pt 1)(Pt 1):229-35. PubMed ID: 1384465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans.
    Corbett JA; Sweetland MA; Wang JL; Lancaster JR; McDaniel ML
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1731-5. PubMed ID: 8383325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide.
    Corbett JA; Wang JL; Sweetland MA; Lancaster JR; McDaniel ML
    J Clin Invest; 1992 Dec; 90(6):2384-91. PubMed ID: 1334975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversibility of interleukin-1 beta-induced islet destruction and dysfunction by the inhibition of nitric oxide synthase.
    Corbett JA; McDaniel ML
    Biochem J; 1994 May; 299 ( Pt 3)(Pt 3):719-24. PubMed ID: 7514870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1 beta-induced formation of EPR-detectable iron-nitrosyl complexes in islets of Langerhans. Role of nitric oxide in interleukin-1 beta-induced inhibition of insulin secretion.
    Corbett JA; Lancaster JR; Sweetland MA; McDaniel ML
    J Biol Chem; 1991 Nov; 266(32):21351-4. PubMed ID: 1657959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide mediates IL-1 beta-induced islet dysfunction and destruction: prevention by dexamethasone.
    Corbett JA; Wang JL; Misko TP; Zhao W; Hickey WF; McDaniel ML
    Autoimmunity; 1993; 15(2):145-53. PubMed ID: 7692996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-1 beta induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: activation of cyclooxygenase by nitric oxide.
    Corbett JA; Kwon G; Turk J; McDaniel ML
    Biochemistry; 1993 Dec; 32(50):13767-70. PubMed ID: 7505613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1 beta-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase.
    Welsh N; Eizirik DL; Bendtzen K; Sandler S
    Endocrinology; 1991 Dec; 129(6):3167-73. PubMed ID: 1720090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The stimulatory effect of IL-1beta on the insulin secretion of rat pancreatic islet is not related with iNOS pathway.
    Jeong IK; Oh SH; Chung JH; Min YK; Lee MS; Lee MK; Kim KW
    Exp Mol Med; 2002 Mar; 34(1):12-7. PubMed ID: 11989973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine kinase inhibitors prevent cytokine-induced expression of iNOS and COX-2 by human islets.
    Corbett JA; Kwon G; Marino MH; Rodi CP; Sullivan PM; Turk J; McDaniel ML
    Am J Physiol; 1996 Jun; 270(6 Pt 1):C1581-7. PubMed ID: 8764139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction.
    Kato Y; Miura Y; Yamamoto N; Ozaki N; Oiso Y
    Diabetologia; 2003 Sep; 46(9):1228-33. PubMed ID: 12898012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine kinase involvement in IL-1 beta-induced expression of iNOS by beta-cells purified from islets of Langerhans.
    Corbett JA; Kwon G; Misko TP; Rodi CP; McDaniel ML
    Am J Physiol; 1994 Jul; 267(1 Pt 1):C48-54. PubMed ID: 7519400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irreversible inhibition of metabolic function and islet destruction after a 36-hour exposure to interleukin-1beta.
    Scarim AL; Heitmeier MR; Corbett JA
    Endocrinology; 1997 Dec; 138(12):5301-7. PubMed ID: 9389514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heat shock inhibits cytokine-induced nitric oxide synthase expression by rat and human islets.
    Scarim AL; Heitmeier MR; Corbett JA
    Endocrinology; 1998 Dec; 139(12):5050-7. PubMed ID: 9832444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of nitric oxide in IL-1 beta-mediated dysfunction of rodent islets of Langerhans. Implications for the function of intrahepatic islet grafts.
    Xenos ES; Stevens RB; Sutherland DE; Lokeh A; Ansite JD; Casanova D; Gores PF; Platt JL
    Transplantation; 1994 Apr; 57(8):1208-12. PubMed ID: 8178348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction.
    Corbett JA; Tilton RG; Chang K; Hasan KS; Ido Y; Wang JL; Sweetland MA; Lancaster JR; Williamson JR; McDaniel ML
    Diabetes; 1992 Apr; 41(4):552-6. PubMed ID: 1376704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1beta-induced nitric oxide production and inhibition of insulin secretion in rat islets of langerhans is dependent upon the nitric oxide synthase cofactor tetrahidrobiopterin.
    Stickings P; Cunningham JM
    Cytokine; 2002 Apr; 18(2):81-5. PubMed ID: 12096922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-1 beta-induced inhibition of beta-cell function is mediated through nitric oxide.
    Xenos ES; Stevens RB; Gores PF; Casanova D; Farney AC; Sutherland DE; Platt JL
    Transplant Proc; 1993 Feb; 25(1 Pt 2):994. PubMed ID: 7680174
    [No Abstract]   [Full Text] [Related]  

  • 20. Interleukin-1 beta-induced nitric oxide synthase expression by rat pancreatic beta-cells: evidence for the involvement of nuclear factor kappa B in the signaling mechanism.
    Kwon G; Corbett JA; Rodi CP; Sullivan P; McDaniel ML
    Endocrinology; 1995 Nov; 136(11):4790-5. PubMed ID: 7588208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.